Literature DB >> 14644504

Analysis of the rat connexin 43 proximal promoter in neonatal cardiomyocytes.

Birgit E J Teunissen1, Anita T Jansen, Shirley C M van Amersfoorth, Terrence X O'Brien, Habo J Jongsma, Marti F A Bierhuizen.   

Abstract

Altered transcriptional control is likely to contribute to the down-regulation of connexin 43 (Cx43) expression observed in many forms of heart disease. However, little is known about the factors regulating Cx43 transcription in the heart under (patho)physiological conditions. Therefore, a systematic study of rat Cx43 (rCx43) proximal promoter regulation in rat primary neonatal ventricular cardiomyocytes (NCM) and, for comparison, different cell types was initiated. Luciferase assays revealed that, in NCM, the proximal promoter is preserved in a conserved region extending from 148 nucleotides upstream towards 281 nucleotides downstream relative to the transcription initiation site (TIS). Further deletional analysis suggested the involvement of four putative Sp- and two AP1-binding sites. The binding of both Sp1 and Sp3 to the Sp-binding elements and AP1 to the AP1-binding elements was demonstrated by electrophoretic mobility shift assays (EMSA). Promoter-luciferase assays using the natural rCx43 proximal promoter and mutated derivatives in NCM, HL-1 and A7r5 cells revealed that all sites contribute to basal promoter activity. Trans-activation of the Cx43 proximal promoter with Sp1 and Sp3 in Drosophila Schneider line 2 (SL2) cells demonstrated that Sp1 and, to a lesser extent, Sp3 determine rCx43 promoter activation. Thus Sp1, Sp3 and AP1 determine basal Cx43 expression. In addition, we studied the effect of the cardiac transcription factor Nkx2.5 on Cx43 regulation. NCM were infected with adenovirus encoding either beta-galactosidase (control) or Nkx2.5. Cx43 protein and mRNA were significantly decreased after Nkx2.5 infection as shown by Western and Northern blot analyses. Promoter-reporter assays demonstrated that the rCx43 promoter was down-regulated approximately twofold upon Nkx2.5 overexpression. Therefore, in NCM, Nkx2.5 appears to play a role in the regulation of Cx43 expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644504     DOI: 10.1016/j.gene.2003.08.011

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

Review 1.  Gap junctions.

Authors:  Morten Schak Nielsen; Lene Nygaard Axelsen; Paul L Sorgen; Vandana Verma; Mario Delmar; Niels-Henrik Holstein-Rathlou
Journal:  Compr Physiol       Date:  2012-07       Impact factor: 9.090

2.  Mitogen-activated protein kinase kinase 4 deficiency in cardiomyocytes causes connexin 43 reduction and couples hypertrophic signals to ventricular arrhythmogenesis.

Authors:  Min Zi; Tomomi E Kimura; Wei Liu; Jiawei Jin; Jonathan Higham; Sanjay Kharche; Guoliang Hao; Ying Shi; Weijian Shen; Sukhpal Prehar; Aleksandr Mironov; Ludwig Neyses; Marti F A Bierhuizen; Mark R Boyett; Henggui Zhang; Ming Lei; Elizabeth J Cartwright; Xin Wang
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

3.  The stress kinase JNK regulates gap junction Cx43 gene expression and promotes atrial fibrillation in the aged heart.

Authors:  Jiajie Yan; Justin K Thomson; Weiwei Zhao; Xiaomin Wu; Xianlong Gao; Dominic DeMarco; Wei Kong; Min Tong; Jun Sun; Mamdouh Bakhos; Vladimir G Fast; Qingrong Liang; Sumanth D Prabhu; Xun Ai
Journal:  J Mol Cell Cardiol       Date:  2017-11-13       Impact factor: 5.000

4.  Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIδ expression in the aged atrium.

Authors:  Xianlong Gao; Xiaomin Wu; Jiajie Yan; Jingqun Zhang; Weiwei Zhao; Dominic DeMarco; Yongguo Zhang; Mamdouh Bakhos; Gregory Mignery; Jun Sun; Zhenyu Li; Michael Fill; Xun Ai
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

5.  An angiotensin II- and NF-kappaB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension.

Authors:  Florian Alonso; Nathalie Krattinger; Lucia Mazzolai; Alexander Simon; Gérard Waeber; Paolo Meda; Jacques-Antoine Haefliger
Journal:  Cardiovasc Res       Date:  2010-01-28       Impact factor: 10.787

Review 6.  Adrenergic control of cardiac gap junction function and expression.

Authors:  Aida Salameh; Stefan Dhein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-02-12       Impact factor: 3.000

7.  Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function.

Authors:  Scott R Johnstone; Angela K Best; Catherine S Wright; Brant E Isakson; Rachel J Errington; Patricia E Martin
Journal:  J Cell Biochem       Date:  2010-06-01       Impact factor: 4.429

8.  Cardiac fibroblasts inhibit β-adrenoceptor-dependent connexin43 expression in neonatal rat cardiomyocytes.

Authors:  A Salameh; H Djilali; K Blanke; J Gonzalez Casanova; S von Salisch; A Savtschenko; S Dhein; I Dähnert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-03       Impact factor: 3.000

9.  c-Jun N-terminal kinase activation contributes to reduced connexin43 and development of atrial arrhythmias.

Authors:  Jiajie Yan; Wei Kong; Qiang Zhang; Eric C Beyer; Gregory Walcott; Vladimir G Fast; Xun Ai
Journal:  Cardiovasc Res       Date:  2012-12-14       Impact factor: 10.787

10.  RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression.

Authors:  Ramesh S Yadava; Carla D Frenzel-McCardell; Qing Yu; Varadamurthy Srinivasan; Amy L Tucker; Jack Puymirat; Charles A Thornton; Owen W Prall; Richard P Harvey; Mani S Mahadevan
Journal:  Nat Genet       Date:  2007-12-16       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.